Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-25

Clinical Trial Update: Serum VEGF as a Tubal Pregnancy Marker

View source ↗

Summary

A completed clinical trial from the University of Sao Paulo General Hospital evaluated serum VEGF as a potential biomarker for tubal (ectopic) pregnancy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Pregnancy, Ectopic | Status: COMPLETED